MAX and neoplasm: In summary, administration of MYCMI-6 to MYCN-dependent tumor-bearing mice resulted in the reduction of MYCN:MAX interaction, tumor cell proliferation and MVD and in induction of apoptosis in the tumor tissue without causing severe side effects.